The global biopsy device market has undergone a phenomenal shift due to the growing adoption of guidance-based biopsy procedures. Biopsy refers to the minimally invasive extraction of suspected abnormalities in tissues for pathophysiological testing. The gradual rise in awareness among the patient population and alarming growth in cancer incidence in the global population that bears a high risk of chronic diseases and cancer are observed to be the prime factors that have led to the growth in demand for biopsy devices in the worldwide market.
Based on product types, the global biopsy devices market is studied for guidance systems, biopsy needles, needle-based biopsy guns, biopsy forceps, and others (curettes and punches) segments. The biopsy guidance systems market is further studied for robotic and manual guidance systems segments. Additionally, the biopsy needles segment is studied for disposable and reusable biopsy needles. Needle based biopsy gun segment is sub-classified into fine needle aspiration, core needle biopsy, and vacuum-assisted biopsy systems markets. Finally, the biopsy forceps segment is studied for hot and cold biopsy forceps markets. This report includes market size and forecast for the segments and their sub-markets, thus mentioned for 2014-2022 (in terms of USD Mn). Additionally, the compounded annual growth rate (CAGR %) for each segment is provided in the study for 2016-2022, considering 2015 as the base year.From the perspective of geographical distribution, the global biopsy devices market is studied for four regional markets, namely, North America, Europe, Asia-Pacific, and the Rest of the World.
Each of these regional markets is further studied for the top national and sub-regional markets.This classification is elucidated as follows:
North America
U.S.
Canada
Europe
The U.K.
Germany
Rest of Europe
Asia-Pacific
Japan
China
Rest of Asia-Pacific
Rest of the World
The Middle East and North Africa
Latin America
Rest
Along with the quantitative information regarding market size and forecast, this report also includes qualitative market information demonstrating the market trends and future outlook of the biopsy devices industry. This report includes a description of the market dynamics: drivers, challenges, opportunities, fractal map analysis for competition assessment, and attractive investment proposition. This study concludes with a company profiles section that includes major information about the key market players operating in the global biopsy devices market.
For this study, the global biopsy device market is analyzed for four major segments: biopsy guidance systems, biopsy needles, needle-based biopsy guns, biopsy forceps, and others. These segments, based on their product variants, are further sub-classified, and their market size and forecast are studied in this report.
Among the mentioned segments, the biopsy guidance systems segment dominates the market regarding revenue share. This segment is further categorized into robotic and manual guidance systems markets. Added precision to biopsy procedures aided through guidance systems, better diagnosis outcome, and improved accuracy are the major factors supporting the growth of the guidance systems market. On the other hand, the needle-based biopsy guns segment is anticipated to progress with a CAGR of close to 8% during 2016-2022. This segment is categorized into fine needle aspiration, core biopsy guns, and vacuum-assisted biopsy gun markets. Among these, the vacuum-assisted biopsy guns segment is undergoing the fastest market growth and is also the largest segment in market size.
Geographically, the global biopsy devices market is categorized into:
North America
Europe
Asia Pacific
Rest of the World
North America is the largest geographical market for biopsy devices, followed by Europe. The earliest adoption of the latest technologies, widespread use of guidance systems in biopsy procedures, and aid from reimbursement policies are the major contributors to the lead of these regions. The rapid development of healthcare infrastructure and an alarming rise in cancer incidence in developing economies of Asia-Pacific will contribute to the rising growth rate of Asia-Pacific and the Rest of the World markets.
Frequently Asked Questions
The market for Biopsy Devices is expected to reach US$ XX Mn by 2022.
The Biopsy Devices market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2015 to 2022.
The base year of this report is 2021.
Hologic, Business Description, Financial Health and Budget Allocation, Product Positions/Portfolio, News Coverage are some of the major players in the global market.
